Literature DB >> 7940989

Role of NO in vascular smooth muscle and cardiac muscle function.

R Schulz1, C R Triggle.   

Abstract

NO is a key transducer of a vasodilator message from the endothelium to vascular smooth muscle. Recently, its actions as a negative inotrope in cardiac muscle have been discovered. In the vasculature, it is synthesized under physiological conditions following activation of a low-output, Ca(2+)-dependent NO synthase (NOS) in endothelial cells. Immune activation triggers the expression of a high-output, Ca(2+)-independent NOS in the vasculature and myocardium, causing the overproduction of NO and significant cardiovascular dysfunction. In this article, Richard Schultz and Chris Triggle briefly review recent findings concerning the role of NO, and other endothelium-derived factors, in vascular smooth muscle function and consider the consequences of its production in the heart.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940989     DOI: 10.1016/0165-6147(94)90321-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  17 in total

1.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

2.  Co-induction of nitric oxide and tetrahydrobiopterin synthesis in the myocardium in vivo.

Authors:  Y Hattori; S Hattori; S Motohashi; K Kasai; S I Shimoda; N Nakanishi
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

3.  Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation.

Authors:  T J Toward; K J Broadley
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes.

Authors:  P V Sulakhe; L Sandirasegarane; J P Davis; X T Vo; W J Costain; R R Mainra
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 5.  Nitric oxide: biological role and clinical uses.

Authors:  M S Kannan; S Guiang; D E Johnson
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

6.  Influence of authentic nitric oxide on basal cytosolic [Ca2+] and Ca2+ release from internal stores in human platelets.

Authors:  K H Le Quan Sang; F Lantoine; M A Devynck
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium.

Authors:  H Nawrath; D Bäumner; J Rupp; H Oelert
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  R Schulz; D L Panas; R Catena; S Moncada; P M Olley; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Quantitative measurement of iNOS expression in melanoma, nasopharyngeal, colorectal, and breast tumors of Tunisian patients: comparative study and clinical significance.

Authors:  Emna Dabbeche-Bouricha; Nadia Hadiji-Abbes; Rania Abdelmaksoud-Damak; Nesrine Alaya; Wajdi Ayadi; Slim Charfi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2015-11-07

Review 10.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.